pulmonary emphysema
Jump to navigation
Jump to search
Introduction
Patients with pulmonary emphysema are the pink puffers of COPD.
Pathology
- centrilobular emphysema is most common type
- generally begins in upper lobes
- panlobular emphysema is less common
- generally begins in lower lobes
- form of emphysema associated with alpha-1 antitrypsin deficiency
- lung compliance is increased
- elastic recoil is decreased
- cor pulmonale is rare
Clinical manifestations
- cough mild to moderate
- production of sputum is variable
- tachypnea
- purse-lipped breathing
- use of accessory muscles
- hyper-resonance to percussion
- decreased &/or adventitious breath sounds (wheezes, crackles, large airway sounds)
- symptoms tend to develop late since destruction of vascular supply generally accompanies airway destruction minimizing VQ mismatch
- infections may exacerbate symptoms
- dyspnea is moderate to marked
- severe weight loss may occur
- clubbing is rare[7]
Laboratory
- alpha-1 antitrypsin in serum if family history
Diagnostic procedures
- pulmonary function testing
- pCO2 is normal is slightly increased
- decreased pO2
- DLCO is decreased
- FEV1 is decreased
- total lung volume is markedly increased
- residual volume is markedly increased
Radiology
- chest radiographs
- often show flattened diaphragms
- lung fields may be hyperlucent with diminished vascular markings
- disease is often most prominent in upper lung fields
- alpha-1 antitrypsin deficiency may show a basilar disease prominence & should be considered in patients < 50 years of age with emphysema
- computed tomography
Differential diagnosis
Management
- see COPD
- lung volume reduction surgery
- benefits patients with predominantly upper lobe emphysema
- consider after course of pulmonary rehabilitation
- appears to provide some benefit by improving mechanical function of thoracic cage compromised by hyperinflation of the lungs
- endobronchial valve(s) may be of modest benefit at a cost of increased risk of pneumonia, COPD exacerbation[3]
- endobronchial coils
- lung transplantation
More general terms
More specific terms
Additional terms
References
- ↑ Manual of Medical Therapeutics, 28th ed, Ewald & McKenzie (eds), Little, Brown & Co, Boston, 1995, pg 242
- ↑ Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 739
- ↑ 3.0 3.1 Sciurba FC et al. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med 2010 Sep 23; 363:1233 PMID: https://www.ncbi.nlm.nih.gov/pubmed/20860505
- ↑ 4.0 4.1 Oelsner EC et al Association Between Emphysema-like Lung on Cardiac Computed Tomography and Mortality in Persons Without Airflow Obstruction: A Cohort Study Ann Intern Med. 2014;161(12):863-873 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25506855 <Internet> http://annals.org/article.aspx?articleid=2023010
- ↑ 5.0 5.1 Deslee G et al. Lung volume reduction coil treatment vs usual care in patients with severe emphysema: The REVOLENS randomized clinical trial. JAMA 2016 Jan 12; 315:175. PMID: https://www.ncbi.nlm.nih.gov/pubmed/26757466
Sciurba FC et al. Bronchoscopic lung volume reduction in COPD: Lessons in implementing clinically based precision medicine. JAMA 2016 Jan 12; 315:139 PMID: https://www.ncbi.nlm.nih.gov/pubmed/26757462 - ↑ 6.0 6.1 Medical Knowledge Self Assessment Program (MKSAP) 17, American College of Physicians, Philadelphia 2015
- ↑ 7.0 7.1 Geriatric Review Syllabus, 11th edition (GRS11) Harper GM, Lyons WL, Potter JF (eds) American Geriatrics Society, 2022